Triethylamine → HCID 15409145, Verbindung
Reaktionsgleichung
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:6]([CH:8]=[C:9]([C:11]([OH:13])=O)[N:10]=2)[CH:7]=1.[CH3:14][O:15][C:16]1[CH:21]=[CH:20][C:19]([N:22]2[CH2:27][CH2:26][NH:25][CH2:24][CH2:23]2)=[CH:18][CH:17]=1.C(P(=O)(OCC)OCC)#N.C(N(CC)CC)C>ClCCl.CN(C=O)C>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:6]([CH:8]=[C:9]([C:11]([N:25]3[CH2:24][CH2:23][N:22]([C:19]4[CH:18]=[CH:17][C:16]([O:15][CH3:14])=[CH:21][CH:20]=4)[CH2:27][CH2:26]3)=[O:13])[N:10]=2)[CH:7]=1Komponenten
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
To 6-chloroimidazo[1,2-a]pyridine-2-carboxylic acid (0.170 g) and 1-(4-methoxyphenyl)piperazine (Aldrich; 0.165 g) in dichloromethane (4 mL) are added diethyl cyanophosphonate (Aldrich; 0.157 mL) and triethylamine (0.144 mL), followed by DMF (2 mL). After stirring overnight, the mixture is quenched with aqueous sodium bicarbonate and then partitioned between dichloromethane and aqueous sodium bicarbonate. The organic layers are filtered through sodium sulfate and concentrated, and the residue is chromatographed on silica gel using methanol/dichloromethane (2/98) to give 0.212 g of 1-[(6-chloroimidazo[1,2-a]pyridin-2-yl)carbonyl]-4-(4-methoxyphenyl)piperazine; mp 180-181° C.: IR (mineral oil) 1620, 1517, 1237, 1246, 1230 cm-1. 1H NMR (CDCl3) δ3.16, 3.78, 3.97, 4.47, 6.86, 6.94, 7.21, 7.56, 8.10,8.20.
Aufarbeitung
- customthe mixture is quenched with aqueous sodium bicarbonate
- custompartitioned between dichloromethane and aqueous sodium bicarbonate
- filtrationThe organic layers are filtered through sodium sulfate
- concentrationconcentrated
- customthe residue is chromatographed on silica gel
Quellen und Nachweise
- ORD-Eintrag
- ord-62e7d426063445229323c54c70bb7967
- Quelldatensatz
- uspto-grants-1999_06
- Patentnummer
- US05912246
Notizen zur Reaktion
Wird geladen…